| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |